Please use this identifier to cite or link to this item:
https://doi.org/10.1186/1471-2458-5-49
DC Field | Value | |
---|---|---|
dc.title | A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial | |
dc.contributor.author | Yang, J | |
dc.contributor.author | Acosta, C.J | |
dc.contributor.author | Si, G.-A | |
dc.contributor.author | Zeng, J | |
dc.contributor.author | Li, C.-Y | |
dc.contributor.author | Liang, D | |
dc.contributor.author | Ochiai, R.L | |
dc.contributor.author | Page, A.-L | |
dc.contributor.author | Danovaro-Holliday, M.C | |
dc.contributor.author | Zhang, J | |
dc.contributor.author | Zhou, B.-D | |
dc.contributor.author | Liao, H.-Z | |
dc.contributor.author | Wang, M.-L | |
dc.contributor.author | Tan, D.-M | |
dc.contributor.author | Tang, Z.-Z | |
dc.contributor.author | Gong, J | |
dc.contributor.author | Park, J.-K | |
dc.contributor.author | Ali, M | |
dc.contributor.author | Ivanoff, B | |
dc.contributor.author | Liang, G.-C | |
dc.contributor.author | Yang, H.-H | |
dc.contributor.author | Pang, T | |
dc.contributor.author | Xu, Z.-Y | |
dc.contributor.author | Donner, A | |
dc.contributor.author | Galindo, C.M | |
dc.contributor.author | Dong, B.-Q | |
dc.contributor.author | Clemens, J.D | |
dc.date.accessioned | 2020-10-20T04:53:32Z | |
dc.date.available | 2020-10-20T04:53:32Z | |
dc.date.issued | 2005 | |
dc.identifier.citation | Yang, J, Acosta, C.J, Si, G.-A, Zeng, J, Li, C.-Y, Liang, D, Ochiai, R.L, Page, A.-L, Danovaro-Holliday, M.C, Zhang, J, Zhou, B.-D, Liao, H.-Z, Wang, M.-L, Tan, D.-M, Tang, Z.-Z, Gong, J, Park, J.-K, Ali, M, Ivanoff, B, Liang, G.-C, Yang, H.-H, Pang, T, Xu, Z.-Y, Donner, A, Galindo, C.M, Dong, B.-Q, Clemens, J.D (2005). A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; Expanding the use of Vi polysaccharide vaccine in Southeast China: A cluster-randomized trial. BMC Public Health 5 : 49. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2458-5-49 | |
dc.identifier.issn | 14712458 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/178033 | |
dc.description.abstract | Background: One of the goals of this study was to learn the coverage, safety and logistics of a mass vaccination campaign against typhoid fever in children and adults using locally produced typhoid Vi polysaccharide (PS) and group A meningococcal PS vaccines in southern China. Methods: The vaccination campaign targeted 118,588 persons in Hechi, Guangxi Province, aged between 5 to 60 years, in 2003. The study area was divided into 107 geographic clusters, which were randomly allocated to receive one of the single-dose parenteral vaccines. All aspects regarding vaccination logistics, feasibility and safety were documented and systematically recorded. Results of the logistics, feasibility and safety are reported. Results: The campaign lasted 5 weeks and the overall vaccination coverage was 78%. On average, the 30 vaccine teams gave immunizations on 23 days. Vaccine rates were higher in those aged ? 15 years (90%) than in adolescents and young adults (70%). Planned mop-up activities increased the coverage by 17%. The overall vaccine wastage was 11%. The cold chain was maintained and documented. 66 individuals reported of adverse events out of all vaccinees, where fever (21%), malaise (19%) and local redness (19%) were the major symptoms; no life-threatening event occurred. Three needle-sharp events were reported. Conclusion: The mass immunization proved feasible and safe, and vaccine coverage was high. Emphasis should be placed on: injection safety measures, community involvement and incorporation of mop-up strategies into any vaccination campaign. School-based and all-age Vi mass immunizations programs are potentially important public health strategies for prevention of typhoid fever in high-risk populations in southern China. © 2005 Yang et al; licensee BioMed Central Ltd. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | hepatitis B vaccine | |
dc.subject | Meningococcus vaccine | |
dc.subject | polysaccharide vaccine | |
dc.subject | typhoid vaccine | |
dc.subject | bacterial antigen | |
dc.subject | bacterial polysaccharide | |
dc.subject | Meningococcus vaccine | |
dc.subject | typhoid paratyphoid vaccine | |
dc.subject | adolescent | |
dc.subject | adult | |
dc.subject | article | |
dc.subject | child | |
dc.subject | China | |
dc.subject | clinical trial | |
dc.subject | cold | |
dc.subject | controlled clinical trial | |
dc.subject | controlled study | |
dc.subject | drug safety | |
dc.subject | drug use | |
dc.subject | feasibility study | |
dc.subject | female | |
dc.subject | fever | |
dc.subject | groups by age | |
dc.subject | health program | |
dc.subject | hepatitis B | |
dc.subject | human | |
dc.subject | infection prevention | |
dc.subject | injection site reaction | |
dc.subject | malaise | |
dc.subject | male | |
dc.subject | mass immunization | |
dc.subject | medical documentation | |
dc.subject | needle | |
dc.subject | normal human | |
dc.subject | randomized controlled trial | |
dc.subject | rash | |
dc.subject | single drug dose | |
dc.subject | statistical analysis | |
dc.subject | storage temperature | |
dc.subject | symptom | |
dc.subject | typhoid fever | |
dc.subject | vaccination reaction | |
dc.subject | cluster analysis | |
dc.subject | geography | |
dc.subject | intramuscular drug administration | |
dc.subject | mass immunization | |
dc.subject | Meningitis, Meningococcal | |
dc.subject | middle aged | |
dc.subject | organization and management | |
dc.subject | public health service | |
dc.subject | safety | |
dc.subject | social marketing | |
dc.subject | subcutaneous drug administration | |
dc.subject | typhoid fever | |
dc.subject | Adolescent | |
dc.subject | Adult | |
dc.subject | Antigens, Bacterial | |
dc.subject | Child | |
dc.subject | China | |
dc.subject | Cluster Analysis | |
dc.subject | Feasibility Studies | |
dc.subject | Geography | |
dc.subject | Humans | |
dc.subject | Injections, Intramuscular | |
dc.subject | Injections, Subcutaneous | |
dc.subject | Mass Vaccination | |
dc.subject | Meningitis, Meningococcal | |
dc.subject | Meningococcal Vaccines | |
dc.subject | Middle Aged | |
dc.subject | Polysaccharides, Bacterial | |
dc.subject | Public Health Administration | |
dc.subject | Safety | |
dc.subject | Social Marketing | |
dc.subject | Typhoid Fever | |
dc.subject | Typhoid-Paratyphoid Vaccines | |
dc.type | Article | |
dc.contributor.department | LEE KUAN YEW SCHOOL OF PUBLIC POLICY | |
dc.description.doi | 10.1186/1471-2458-5-49 | |
dc.description.sourcetitle | BMC Public Health | |
dc.description.volume | 5 | |
dc.description.page | 49 | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_1471-2458-5-49.pdf | 2.36 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License